Elicio Therapeutics share price logo

Elicio Therapeutics

NASDAQ: ELTX

$1.89

+0.02

(+1.34%)

as on

Elicio Therapeutics Stock Performance

as on September 19, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $1.87
    $2.00
    downward going graph

    1.06%

    Downside

    5.82%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.71
    $16.00
    downward going graph

    9.79%

    Downside

    746.56%

    Upside

    downward going graph

Elicio Therapeutics share price movements today

Previous Close
$1.86
Open
$1.87
Volume
432.3K
Market Cap
$46.5M
Day's Low - High
$1.87 - $2.00
52 Week Low - High
$1.71 - $16.00

Elicio Therapeutics Historical Returns

1 Month Return
-40.42 %
3 Month Return
-51.56 %
1 Year Return
-83.52 %
3 Year Return
-77.31 %
5 Year Return
0 %

Elicio Therapeutics Stock Fundamentals & Key Indicators

Check Elicio Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$46.5M

EPS (TTM)

-2.13

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.93

Industry PE ratio

-2.37

PEG Ratio

-0.012873247233166527

EBITDA

-40.5M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-1266.43%

Elicio Therapeutics Stock Valuation

Track how Elicio Therapeutics P/E has moved over time to understand its valuation trends.

Elicio Therapeutics in the last 5 years

  • Overview

  • Trends

Lowest (-3.09x)

December 31, 2025

Today (-3.09x)

December 31, 2025

Industry (-2.37x)

December 31, 2025

Highest (-0.65x)

December 31, 2022

LowHigh

Today’s Price to Earnings Ratio: -3.09x

Elicio Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Elicio Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$46.5MNA-0.930.00%0.00%
BUY$63.1B-63.24%-19.81-12.57%0.00%
BUY$130.1B174.21%29.8186.04%0.00%
BUY$79.7B21.1%18.4884.86%0.48%

Stock Returns calculator for Elicio Therapeutics Stock including INR - Dollar returns

The Elicio Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Elicio Therapeutics investment value today

Current value as on today

₹18,129

Returns

-₹81,871

(-81.87%)

Returns from Elicio Therapeutics Stock

-₹83,304 (-83.3%)

Dollar Impact

₹1,433 (+1.43%)

Analyst Recommendation on Elicio Therapeutics Stock

Based on 2 analysts

BUY

50.00%

Buy

50.00%

Hold

0.00%

Sell

Based on 2 analysts, 50% of analysts recommend a 'BUY' rating for Elicio Therapeutics. Average target price of $16.5

Elicio Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Elicio Therapeutics.

What analysts predicted

88.55%UPSIDE

Target Price

$16.5

Current Price

$1.89

Analyzed by

2 Analysts

Target

$16.50

Elicio Therapeutics target price $16.5, a slight upside of 88.55% compared to current price of $1.89. According to 2 analysts rating.

Indian Investors' Interest in Elicio Therapeutics Stock

Search interest for Elicio Therapeutics Stock has decreased by -25% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-25% versus previous 30 day period

Elicio Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
0
-
-
-
0
-
Operating Income
-9
-10
-10
-10
-10
-10
-8
-8
-10
-10
EBITDA
-8
-11
-6
-18
-10
-10
-9
-7
-11
-12
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
-
Income Before Tax
-8
-11
-7
-18
-11
-10
-10
-7
-11
-8
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-8
-11
-7
-18
-11
-10
-10
-7
-11
-8
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Elicio Therapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Mar 2025
Dec 2025
Total Revenue
4
1
2
28
-
-
-
-
Gross Profit
3
0
1
27
-1
-1
-1
-1
Operating Income
-14
-38
-55
-39
-23
-35
-44
-37
EBITDA
-14
-40
-70
-51
-23
-32
-50
-37
Interest Expense
-
-
8
0
3
1
0
1
Depreciation
0
0
0
0
1
1
1
1
Income Before Tax
-20
-40
-80
-54
-28
-35
-51
-39
Income Tax Expense
-
-
-
-
-
-
-
-
Net Income
-20
-40
-80
-26
-28
-35
-51
-39
Net Profit Margin
90.57%
23.60%
36.88%
95.64%
0.00%
0.00%
0.00%
0.00%

Elicio Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-8
-11
-7
-18
-11
-10
-10
-7
-11
-8
Operating Cash Flow
-9
-12
-8
-7
-10
-8
-11
-6
-11
-8
Investing Cash Flow
-
0
0
-
-
-
-
0
-
-
Financing Cash Flow
7
11
0
30
10
11
9
4
8
16
Change in Cash
-2
-1
-8
23
0
3
-1
-2
-3
8

Elicio Therapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Mar 2025
Dec 2025
Net Income
-20
-40
-80
-26
-28
-35
-51
-39
Operating Cash Flow
-8
-24
-22
-23
-22
-32
-37
-36
Investing Cash Flow
-
0
0
0
0
0
0
0
Financing Cash Flow
31
4
52
19
21
38
42
36
Change in Cash
23
-19
29
-5
-80
5
5
0

Mutual Funds that own Elicio Therapeutics Stock

Check out the Mutual Funds with significant holdings in Elicio Therapeutics.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
1.923317%
505484
Fidelity Concord Street Trust
0.416979%
109590
VANGUARD INSTITUTIONAL INDEX FUNDS
0.025032%
6579
VANGUARD VALLEY FORGE FUNDS
0.025017%
6575
Victory Portfolios III
0.004957%
1303

Global Institutional Holdings in Elicio Therapeutics

Funds
Holdings
Vanguard
2.47%
iShares
1.86%
Xtrackers
0.04%
Global X
0.02%
ProShares
0.01%

Insights on Elicio Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 510.3% return, outperforming this stock by 593.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 48.8% return, outperforming this stock by 127.0%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, ELTX stock has moved down by -38.5%

About Elicio Therapeutics

Elicio Therapeutics, Inc. is a clinical-stage biotechnology firm dedicated to creating a diverse array of innovative immunotherapies for the treatment of various cancers and other diseases. The company's primary experimental drug, ELI-002, is an AMP therapeutic vaccine specifically formulated to target KRAS-driven cancers. Its development portfolio also encompasses ELI-004, an AMP-modified CpG adjuvant that forms part of ELI-002; ELI-007, a lymph node-targeted AMP-peptide vaccine addressing mutant BRAF-driven cancers; and ELI-008, a multivalent lymph node-targeted AMP-peptide vaccine for cancers expressing mutant TP53. Furthermore, Elicio is advancing ELI-005, a vaccine candidate for preventing COVID-19, and ELI-011 for hematological malignancies. Another program, ELI-012, is an mKRAS TCR T cell AMP-lifier designed for combined use with mKRAS-targeted TCR T cell therapy against mKRAS-driven cancers. The company's operations are headquartered in Boston, Massachusetts.
OrganisationElicio Therapeutics
Headquarters451 D Street, Boston, MA, 02210, US
IndustryBiotechnology
CEORobert T. Connelly
E-voting on sharesClick here to vote

Key Management of Elicio Therapeutics

Name

Title

Mr. Marc J. Wolfgang M.S.

Chief Technology Officer

Dr. Peter DeMuth Ph.D.

Chief Scientific Officer

Dr. Preetam Shah M.B.A., Ph.D.

Chief Strategy & Financial Officer and Treasurer

Dr. Darrell J. Irvine Ph.D.

Co-Founder, Consultant, Board Observer & Chairman of Scientific Advisory Board

Dr. Christopher M. Haqq M.D., Ph.D.

Executive VP, Head of Research & Development and Chief Medical Officer

Ms. Megan C. Filoon

General Counsel, Secretary & Compliance Officer

Ms. Esther Welkowsky

Senior Vice President of Clinical Development

Ms. Joy Seymour

Senior VP & Head of Regulatory Affairs

Mr. Robert T. Connelly

CEO, President & Director

Dr. Allen Richard Nissenson F.A.S.N., FACP, M.D.

Founder & Independent Director

FAQs

What is Elicio Therapeutics share price today?

Elicio Therapeutics share price today is $1.89 as on at the close of the market. Elicio Therapeutics share today touched a day high of $2.00 and a low of $1.87.

What is the 52 week high and 52 week low for Elicio Therapeutics share?

Elicio Therapeutics share touched a 52 week high of $16.00 on and a 52 week low of $1.71 on . Elicio Therapeutics stock price today i.e. is closed at $1.89,which is 88.19% down from its 52 week high and 10.85% up from its 52 week low.

What is Elicio Therapeutics's market capitalisation today?

Elicio Therapeutics market capitalisation is $0.00T as on .

How to invest in Elicio Therapeutics Stock (ELTX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Elicio Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Elicio Therapeutics Shares that will get you 0.7937 shares as per Elicio Therapeutics share price of $1.89 per share as on September 19, 2026 at 8:46 am IST.

What is the minimum amount required to buy Elicio Therapeutics Stock (ELTX) from India?

Indian investors can start investing in Elicio Therapeutics (ELTX) shares with as little as ₹95.88 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.80 in Elicio Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Elicio Therapeutics share’s latest price of $1.89 as on September 19, 2026 at 8:46 am IST, you will get 5.2910 shares of Elicio Therapeutics. Learn more about fractional shares .